Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
3D Bioprinting Market Worth $2.4 billion | MarketsandMarkets™
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170201787 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170201787 Browse in-depth TOC on "3D Bioprinting Market" 530 - Tables46 - Figures453 - Pages 3D Bioprinting Market Scope: The 3D Bioprinters segment segment is expected to have the dominant share of the 3D bioprinting market in 2023. Based on component, the global 3D...
PR Newswire
17/05/2024
Novo Nordisk A/S - share repurchase programme
Bagsværd, Denmark, 17 May 2024– On 6 May 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules"). This programme is part of the overall share repurchase programme of up to DKK 20 billion to be executed during a 12-month period beginning 6 February 2024. Under the…
Nasdaq GlobeNewswire
17/05/2024
Active Pharmaceutical Ingredient Market Worth $238.3 billion |…
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=263 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=263 Browse in-depth TOC on "Active Pharmaceutical Ingredient Market" 692 - Tables 65 - Figures 562 - Pages Active Pharmaceutical Ingredient Market Scope: The traditional API segment accounted for the largest share, by potency in the active pharmaceutical ingredients market in 2023...
PR Newswire
17/05/2024
HOYA Group Company, PENTAX of America, Inc. and MAGENTIQ EYE Ltd. Announce their…
MAGENTIQ-COLO™ is a cutting-edge system for the detection of gastrointestinal lesions in colonoscopies. Successfully validated in an international multicenter, randomized, controlled trial (RCT) with 950 enrolled patients at 10 hospitals in Europe, United States and Israel, its outstanding diagnostic capabilities are setting new standards in endoscopic AI. MAGENTIQ-COLO™ is a cutting-edge system for the detection of gastrointestinal lesions in colonoscopies. Successfully validated in an...
PR Newswire
17/05/2024
HIVE FURNITURE SHOW ANNOUNCES FOURTH EDITION, HOSTS 215 GLOBAL EXHIBITORS
The show also introduces Hive Conclave for the first time, which hosts leading players in the furniture industry to shed light on the latest trends and highlight the furniture industry's insights in the region. The show also introduces Hive Conclave for the first time, which hosts leading players in the furniture industry to shed light on the latest trends and highlight the furniture industry's insights in the region. Gautam Mulani, co-founder of Hive Furniture Show, said: "We look…
PR Newswire
17/05/2024
Trading by management and close relations of management
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B in the attached file.Investor Relations Tobias Bjorklund+45 3077 8682 tobb@novonesis.com Anders Enevoldsen+45 5350 1453 ...
Nasdaq GlobeNewswire
17/05/2024
Notification of managers' transactions
ANNOUNCEMENT NO. 268 Notification of managers' transactions ChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation no. 596/2014 of transactions related to shares in ChemoMetec A/S made by persons discharging managerial responsibilities in ChemoMetec A/S and/or persons closely associated with them.See the transactions of the Chair of ChemoMetec's Board of Directors Niels Thestrup in the attached PDF document. For further information,...
Nasdaq GlobeNewswire
17/05/2024
Brainomix Achieves Breakthrough with FDA Clearance of e-Lung AI Software
Dr Deji Adegunsoye, Assistant Professor of Medicine and Scientific Director of the Interstitial Lung Disease Program at University of Chicago Medicine, said: "This is an exciting step for Brainomix, who have a demonstrated track record of developing novel AI-based solutions in stroke and are now applying that expertise to develop innovative tools in the lung space. The preliminary data for e-Lung is impressive and would indicate that we have a promising tool that could help to expedite…
PR Newswire
17/05/2024
QuTEM Receives GMP Certificates and Manufacturing Permits for Transmission…
GMP regulations are formal standards established by regulatory bodies worldwide to ensure the quality, safety, and efficacy of pharmaceutical products. Manufacturing Permits for Independent Quality Control Laboratories are granted by the Swedish regulatory authority since January 2024 to laboratories that conduct tests directly impacting the release of medicines. The GMP certificates and manufacturing permits are a testament to QuTEM's commitment to biopharma drug development and quality...
Nasdaq GlobeNewswire
17/05/2024
Monthly information on share capital and company voting rights
(Article 223-16 of General Regulation of the French financial markets authority) PARIS, May16, 2024(GLOBE NEWSWIRE) -- Listing market: Euronext GrowthISIN code: FR0010425595DateTotal number of shares in the capitalTotal number of voting rights 05/03/202499,955,53587,891,239For further information on Cellectis, please contact: Media contact: Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33,media@cellectis.com...
Nasdaq GlobeNewswire
16/05/2024
DBV Technologies Announces Results of its 2024 Combined General Meeting
DBV Technologies Announces Results of its 2024 Combined General Meeting Shareholders approved all proposed resolutions DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT) (the “ Company ”), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, held its Combined General Meeting (the “ General Meeting ”). The General Meeting was chaired by Michel de...
Nasdaq GlobeNewswire
16/05/2024
Voting Rights and Shares Capital of the Company
In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)PARIS, May16, 2024(GLOBE NEWSWIRE) --Market: Euronext Paris / Nasdaq Euronext Compartment: BISIN code: FR0011341205 Nasdaq: NBTX Bloomberg: NANO:FP Reuters: NANO.PA Website:www.nanobiotix.comDateNumber of Shares OutstandingTotal number of voting rightsTotal voting rights,...
Nasdaq GlobeNewswire
16/05/2024
Galapagos creates new subscription right plans
Mechelen, Belgium; 16 May 2024, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its Board of Directors created 1,614,000 subscription rights under new subscription right plans for the benefit of certain members of the personnel of the company and its subsidiaries.On 16 May 2024, the Board of Directors of Galapagos approved “Subscription Right Plan 2024 BE”, intended for members of personnel of the company, “Subscription Right Plan 2024...
Nasdaq GlobeNewswire
16/05/2024
Inventiva announces the positive recommendation of the fourth DMC of the NATiV3…
The Data Monitoring Committee recommended to continue the clinical trial without modification of the current protocol, based on the pre-planned review of safety data.The recommendation was based on the unblinded review by the DMC of safety data from more than 900 patients randomized in the main and exploratory cohorts, including more than 360 and 80 patients that have been treated for more than 48 and 72 weeks, respectively.The patient who experienced the adverse event of increased liver...
Nasdaq GlobeNewswire
16/05/2024
The US Garden Hand Tools Market to Reach $3.80 Billion by 2029 - Southern Region…
Browse in-depth TOC on the US Garden Hand Tools Market125 – Tables 85 – Figures 296 – Pages Browse in-depth TOC on the US Garden Hand Tools Market125 – Tables 85 – Figures 296 – Pages The U.S. Garden Hand Tools Market Report Scope The US garden hand tool industry is heading toward sophistication and customization of products to keep ahead of the other players in the market. Technological advances and the use of battery-driven tools...
PR Newswire
16/05/2024
Glutamine Sales Set to Total USD 199 Million by 2034 Amid Growing Health and…
Sales remain particularly high for L-glutamine owing to its perceived health benefits. The target segment accounted for a revenue share of 63% in 2023 and is set to experience steady growth through 2034. Sales remain particularly high for L-glutamine owing to its perceived health benefits. The target segment accounted for a revenue share of63%in 2023 and is set to experience steady growth through 2034. Download the Sample PDF report to explore key market insights and trends:...
PR Newswire
16/05/2024
The US Emergency Medical Services (EMS) Market to Reach $26.20 Billion by 2029…
To Know More, Click: https://www.focusreports.store/report/us-emergency-medical-services-market To Know More, Click:https://www.focusreports.store/report/us-emergency-medical-services-market The US Emergency Medical Services (EMS) Market Report Scope The demand for emergency medical services is rising due to multiple factors, including the rising number of baby boomers, the growing aging population, the increase in healthcare expenditure, and rising road accidents. The US is the...
PR Newswire
16/05/2024
Radiopharmaceutical CDMO/CMO Services Market to Reach USD 5.44 Billion by 2031 -…
Radiopharmaceuticals, which contain radioactive isotopes, are crucial in nuclear medicine for both diagnostic imaging and therapeutic purposes. These drugs emit radiation that medical imaging devices can detect, aiding in visualizing and diagnosing various medical conditions. Radiopharmaceuticals, which contain radioactive isotopes, are crucial in nuclear medicine for both diagnostic imaging and therapeutic purposes. These drugs emit radiation that medical imaging devices can detect, aiding…
PR Newswire
16/05/2024
Oxurion Receives Transparency Notification from Atlas Special Opportunities…
Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – May 16, 2024 – 07:00 PM CET(Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency legislation 1it has received a transparency notification as follows: Oxurion received a transparency notification on May 16, 2024, from Atlas Special Opportunities, LLC indicating that as of May 13, 2024, it held 1,000,850,000...
Nasdaq GlobeNewswire
16/05/2024
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order
The OSC had previously granted, on February 29, 2024, a management cease trade order, which has been been revoked and replaced by the FFCTO dated May 15, 2024. The OSC had previously granted, onFebruary 29, 2024, a management cease trade order, which has been been revoked and replaced by the FFCTO datedMay 15, 2024. The Company is working diligently to facilitate the completion of the Required Annual Filings and the Required Interim Filings and expects to be in a position to file in...
PR Newswire
16/05/2024
King Faisal Specialist Hospital & Research Centre Wins 2024 Tech Impact Award…
RIYADH, Saudi Arabia, May16, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) has achieved a significant milestone by winning the 2024 Tech Impact Award, a prestigious recognition presented by the Value-Based Health Care Centre Europe. This accolade, awarded for its pioneering Home Hemodialysis (HHD) initiative, underscores KFSHRC's unwavering commitment to comprehensive healthcare and further cement its position as a global leader in the...
Nasdaq GlobeNewswire
16/05/2024
Circle Cardiovascular Imaging Partners with inHEART to Distribute AI-Driven…
Circle Cardiovascular Imaging (CVI) is known for its multi-modal AI-based solutions that streamline cardiac imaging and reporting workflows across the cardiac service line, including coronary artery disease, heart failure, and structural heart disease. The Circle cvi42 platform offers easy-to-use, clinically validated tools that integrate seamlessly into existing clinical workflows to aid clinicians with quantification of cardiac function and flow, visualization of tissue abnormalities…
PR Newswire
16/05/2024
Lab Automation Market to be Worth $11.31 Billion by 2031 - Exclusive Report by…
Lab automation refers to the use of automated systems, instruments, and software to streamline and optimize various laboratory processes and tasks. It involves the deployment of automated systems and technologies that are intended to enhance efficiency and accuracy in laboratory processes. Lab automation refers to the use of automated systems, instruments, and software to streamline and optimize various laboratory processes and tasks. It involves the deployment of automated systems and...
PR Newswire
16/05/2024
Newborn Screening Market to be Worth $2.69 Billion by 2031 - Exclusive Report by…
Newborn screening is a screening program for infants under which pre-symptomatic congenital conditions are detected so that treatment can be commenced as soon as possible to prevent or reduce the long-term consequences of the disease. These programs are usually run by the national or state governing bodies with the aim of screening all infants for a defined panel of disorders that are treatable. These tests include hearing, blood, pulse oximetry, and other similar tests and benefit the newborn…
PR Newswire
16/05/2024
Altri Comunicati
